CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Enterra Multi-Channel Phased Gastric Pacemaker (MGP-1)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00595621
NCT00595621N/ACompleted
CompareCT.gov

Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis

University of Kansas Medical Center·interventional·Posted Jan 16, 2008·Updated May 31, 2019

In Brief

A clinical study evaluating Enterra Multi-Channel Phased Gastric Pacemaker (MGP-1) for Gastric Stasis. Completed, enrolled 22 participants across 1 site.

Detailed Summary

Investigate the safety and efficacy of multi-channel gastric electrical stimulation in the treatment of patients with severe diabetic gastroparesis refractory to standard therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastric Stasis
CountriesUnited States
CollaboratorsGI Stimulation, Inc., National Institutes of Health (NIH), American Diabetes Association

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 16, 2008
Enrollment StartFeb 1, 2006
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 18.5 years ago

Interventions

Enterra Multi-Channel Phased Gastric Pacemaker (MGP-1)device

Multi-Channel Phased Gastric Pacemaker (MGP-1)